Skip to main content

Find Clinical Trials

Home
Conditions
Graft Versus Host Disease

Clinical trial condition

Graft Versus Host Disease

Explore clinical trials studying Graft Versus Host Disease. Study availability and eligibility vary by location and protocol.

129 public trials 13 recruiting studies

Refine in advanced search Browse all conditions

Graft Versus Host Disease trial results

Completed

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004232

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +87 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

NCT00003335

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +56 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation

NCT00146614

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Hematologic Diseases, +6 more
Locations: Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

NCT00144677

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +28 more
Locations: Dana-Farber Cancer Center Boston, Massachusetts, United States

View Trial Details

Completed

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

NCT00002456

Conditions: Chronic Disease, Disease Attributes, Graft Versus Host Disease, +20 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

NCT00089037

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +70 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract

NCT00055666

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

NCT00003662

Conditions: Anemia, Anemia, Refractory, Bone Marrow Diseases, +16 more
Locations: University of Florida Health Science Center Gainesville, Florida, United States

Division of Pediatric Surgery Jacksonville, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois, United States

View all 15 locations

View Trial Details

Completed

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

NCT00003894

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases, +2 more
Locations: Arkansas Children's Hospital Little Rock, Arkansas, United States

University of Kansas Medical Center Kansas City, Kansas, United States

Louisiana State University School of Medicine New Orleans, Louisiana, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

NCT00003661

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +54 more
Locations: University of Florida Health Science Center Gainesville, Florida, United States

Division of Pediatric Surgery Jacksonville, Florida, United States

Nemours Children's Clinic Jacksonville, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View all 17 locations

View Trial Details